Shufro Rose & Co’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-3,400
| Closed | -$292K | – | 330 |
|
|
2022
Q4 | $292K | Sell |
3,400
-1,268
| -27% | -$100K | 0.02% | 242 |
|
|
2022
Q3 | $288K | Buy |
4,668
+29
| +0.6% | +$1.83K | 0.03% | 227 |
|
|
2022
Q2 | $287K | Hold |
4,639
| – | – | 0.02% | 228 |
|
|
2022
Q1 | $276K | Sell |
4,639
-700
| -13% | -$44.7K | 0.02% | 238 |
|
|
2021
Q4 | $388K | Hold |
5,339
| – | – | 0.03% | 205 |
|
|
2021
Q3 | $373K | Sell |
5,339
-500
| -9% | -$35.1K | 0.03% | 199 |
|
|
2021
Q2 | $402K | Hold |
5,839
| – | – | 0.03% | 196 |
|
|
2021
Q1 | $377K | Hold |
5,839
| – | – | 0.03% | 193 |
|
|
2020
Q4 | $340K | Sell |
5,839
-500
| -8% | -$30.2K | 0.03% | 199 |
|
|
2020
Q3 | $401K | Buy |
6,339
+32
| +0.5% | +$2.22K | 0.04% | 176 |
|
|
2020
Q2 | $485K | Buy |
6,307
+1,007
| +19% | +$77.2K | 0.05% | 153 |
|
|
2020
Q1 | $396K | Hold |
5,300
| – | – | 0.05% | 163 |
|
|
2019
Q4 | $344K | Buy |
5,300
+500
| +10% | +$32.6K | 0.03% | 211 |
|
|
2019
Q3 | $304K | Hold |
4,800
| – | – | 0.03% | 221 |
|
|
2019
Q2 | $324K | Hold |
4,800
| – | – | 0.03% | 209 |
|
|
2019
Q1 | $312K | Hold |
4,800
| – | – | 0.03% | 212 |
|
|
2018
Q4 | $300K | Sell |
4,800
-100
| -2% | -$6.99K | 0.03% | 206 |
|
|
2018
Q3 | $378K | Hold |
4,900
| – | – | 0.04% | 200 |
|
|
2018
Q2 | $347K | Sell |
4,900
-15
| -0.3% | -$1.06K | 0.03% | 208 |
|
|
2018
Q1 | $371K | Hold |
4,915
| – | – | 0.04% | 199 |
|
|
2017
Q4 | $352K | Buy |
4,915
+15
| +0.3% | +$1.14K | 0.03% | 203 |
|
|
2017
Q3 | $397K | Hold |
4,900
| – | – | 0.04% | 189 |
|
|
2017
Q2 | $347K | Buy |
4,900
+400
| +9% | +$26.6K | 0.04% | 192 |
|
|
2017
Q1 | $306K | Buy |
4,500
+700
| +18% | +$49.2K | 0.03% | 205 |
|
|
2016
Q4 | $272K | Sell |
3,800
-55
| -1% | -$4.09K | 0.03% | 210 |
|
|
2016
Q3 | $305K | Sell |
3,855
-345
| -8% | -$28K | 0.03% | 198 |
|
|
2016
Q2 | $350K | Hold |
4,200
| – | – | 0.04% | 183 |
|
|
2016
Q1 | $386K | Buy |
4,200
+500
| +14% | +$45.1K | 0.04% | 180 |
|
|
2015
Q4 | $374K | Sell |
3,700
-20
| -0.5% | -$2.08K | 0.04% | 172 |
|
|
2015
Q3 | $365K | Sell |
3,720
-280
| -7% | -$31.1K | 0.04% | 176 |
|
|
2015
Q2 | $468K | Sell |
4,000
-1,000
| -20% | -$109K | 0.05% | 161 |
|
|
2015
Q1 | $490K | Hold |
5,000
| – | – | 0.05% | 164 |
|
|
2014
Q4 | $471K | Sell |
5,000
-100
| -2% | -$10.3K | 0.05% | 171 |
|
|
2014
Q3 | $542K | Buy |
5,100
+100
| +2% | +$9.79K | 0.06% | 162 |
|
|
2014
Q2 | $414K | Sell |
5,000
-1,000
| -17% | -$77.8K | 0.04% | 181 |
|
|
2014
Q1 | $425K | Sell |
6,000
-3,000
| -33% | -$235K | 0.04% | 174 |
|
|
2013
Q4 | $675K | Hold |
9,000
| – | – | 0.07% | 139 |
|
|
2013
Q3 | $565K | Sell |
9,000
-300
| -3% | -$17.9K | 0.06% | 145 |
|
|
2013
Q2 | $476K | Buy |
+9,300
| New | +$485K | 0.06% | 154 |
|
Other funds holding GILD
Shufro Rose & Co's GILD Position: Q1 2023 in Review
Shufro Rose & Co sold out of Gilead Sciences (GILD) in Q1 2023, closing a stake of 3,400 shares — an estimated $292K sold.
Shufro Rose & Co first reported a position in GILD in Q2 2013 and held it in 39 quarters. The position peaked at $675K in Q4 2013. 1,735 funds tracked by Wall St. Rank hold GILD as of Q1 2023.
- Shufro Rose & Co reported no remaining Gilead Sciences position as of Q1 2023 after selling out during the quarter.
- Shufro Rose & Co sold 3,400 Gilead Sciences shares in Q1 2023, an estimated $292K.
- Shufro Rose & Co first reported a position in Gilead Sciences in Q2 2013 and held it in 39 quarters.
- Shufro Rose & Co's Gilead Sciences position peaked at $675K in Q4 2013.
- 1,735 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2023.
Based on Shufro Rose & Co's 13F filing for Q1 2023, filed 20 Apr 2023.